Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9388208
APP PUB NO 20150133395A1
SERIAL NO

14534715

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are formulations, methods and substituted tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GILEAD SCIENCES, INC.;ROSEMOUNT INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clarke, Michael O'Neil Hanrahan Redwood City, US 36 700
Doerffler, Edward Foster City, US 29 649
Mackman, Richard L Millbrae, US 115 2367
Siegel, Dustin San Carlos, US 50 686

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 12, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 12, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00